Stay updated with breaking news from Caredx Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Several brokerages have updated their recommendations and price targets on shares of CareDx (NASDAQ: CDNA) in the last few weeks: 5/31/2024 – CareDx had its “neutral” rating reaffirmed by analysts at HC Wainwright. 5/29/2024 – CareDx was downgraded by analysts at StockNews.com from a “buy” rating to a “hold” rating. 5/21/2024 – CareDx was upgraded […]
CareDx, Inc. , The Transplant Companytm ? a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers ? today...
CareDx (NASDAQ:CDNA – Free Report) had its target price hoisted by Craig Hallum from $15.00 to $22.00 in a research note issued to investors on Friday morning, Benzinga reports. Craig Hallum currently has a buy rating on the stock. CDNA has been the topic of several other research reports. The Goldman Sachs Group raised their […]
CareDx (NASDAQ:CDNA – Free Report) had its price objective boosted by Stephens from $15.00 to $18.00 in a research report report published on Monday morning, Benzinga reports. Stephens currently has an overweight rating on the stock. Several other brokerages have also recently weighed in on CDNA. StockNews.com upgraded CareDx from a hold rating to a […]
NEW YORK, May 14, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating...